SPINK5 and Netherton syndrome: In Netherton syndrome, which is another skin disease that has been associated with AD, a loss-of-function mutation in the serine protease inhibitor of kazal type 5) gene, which encodes LEKTI (lympho-epithelial kazal type related inhibitor type 5 (SPINK5) in humans, was reported to play a significant role.